Reproductive Medicine and Biology, an esteemed journal published by WILEY, stands at the forefront of advancements in the field of reproductive health and associated biological sciences. With an impact factor that underscores its relevance—ranking in Q1 for Reproductive Medicine and Q3 in Cell Biology—this journal is distinguished by its commitment to disseminating high-quality, peer-reviewed research since its transition to Open Access in 2002. Based in Japan, the journal caters to a global audience, providing vital insights into reproductive biology, therapeutics, and innovative practices. With Scopus rankings placing it at #22 out of 90 in Reproductive Medicine and a commendable percentile ranking, Reproductive Medicine and Biology aims to foster dialogue and knowledge transfer among researchers, professionals, and students, paving the way for breakthroughs in understanding reproductive health.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Reproductive Sciences is a premier journal published by SPRINGER HEIDELBERG, dedicated to the field of obstetrics and gynecology. With its ISSN 1933-7191 and E-ISSN 1933-7205, the journal has established itself as a leading source of high-quality research and clinical insights since its inception in 2007, and continues to converge its scope into 2024. Currently ranked in the Q1 category for obstetrics and gynecology, it holds the 43rd position among 209 journals in the Scopus rankings, underscoring its influence and relevance within the medical community. This journal is particularly dedicated to advancing knowledge in reproductive health, providing a platform for innovative research and clinical practices through both traditional and open access options. Located in Switzerland with an address in Heidelberg, Germany, Reproductive Sciences is not just a publication; it is a vital resource for researchers, professionals, and students seeking to make impactful contributions to the field of reproductive health.

The JOURNAL OF REPRODUCTIVE IMMUNOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal platform for exploring the intricate interactions between reproductive health and the immune system. With an ISSN of 0165-0378 and an E-ISSN of 1872-7603, this esteemed journal spans over four decades, from 1979 to 2024, contributing significantly to the fields of Immunology, Reproductive Medicine, and Obstetrics and Gynecology. Currently ranked in Q2 for Immunology and Allergy and Q1 for both Obstetrics and Gynecology and Reproductive Medicine, it serves as an invaluable resource for researchers, professionals, and students dedicated to advancing knowledge in reproductive health. The journal’s notable impact factor and rigorous peer-review process underscore its commitment to high-quality research, making it an essential reference point for ongoing studies in this ever-evolving discipline. By promoting interdisciplinary discussions and pioneering research findings, the JOURNAL OF REPRODUCTIVE IMMUNOLOGY fosters a deeper understanding of the immune mechanisms that influence reproductive outcomes.

MOLECULAR REPRODUCTION AND DEVELOPMENT is a prestigious peer-reviewed journal published by WILEY, specializing in the intricate domains of Cell Biology, Developmental Biology, and Genetics. Since its inception in 1988, this journal has been a vital platform for disseminating pioneering research and innovative methodologies that advance our understanding of molecular mechanisms driving reproduction and development. With a current impact factor reflective of its significance in the field, MOLECULAR REPRODUCTION AND DEVELOPMENT is ranked Q3 in both Cell Biology and Developmental Biology, and Q2 in Genetics, underscoring its relevance and scholarly contribution. Catering to a diverse audience of researchers, professionals, and students, this journal not only showcases cutting-edge findings but also aims to foster interdisciplinary exchanges that enhance scientific collaboration. By exploring critical biological processes, it ultimately contributes to the broader understanding of health and disease in various organisms, making it an essential resource for anyone dedicated to the life sciences.

MOLECULAR HUMAN REPRODUCTION, published by Oxford University Press, is a pivotal journal dedicated to advancing the field of reproductive biology. Since its inception in 1995, the journal has been recognized for its rigorous peer-reviewed research and substantial contributions to the understanding of molecular mechanisms underlying human reproduction. With an impressive impact factor and ranked within the top tiers (Q1 and Q2) across diverse categories including Embryology, Obstetrics and Gynecology, and Reproductive Medicine, it stands as an essential resource for researchers, healthcare professionals, and students alike. The journal aims to publish cutting-edge research that explores the complexities of human reproduction at the molecular and cellular levels, fostering a deeper understanding that can be translated into clinical practice. Although it currently operates under a subscription model, the valuable insights and groundbreaking findings featured within its pages continue to influence the trajectory of reproductive health research globally. Located in the heart of Oxford, United Kingdom, the journal remains committed to addressing vital challenges in the field and promoting innovative scientific dialogue.

Jornal Brasileiro de Reprodução Assistida is a prominent academic journal focusing on the latest advancements in reproductive medicine, published by the Sociedade Brasileira de Reprodução Assistida (SBRA). With an ISSN of 1517-5693 and an E-ISSN of 1518-0557, this journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of obstetrics and gynecology. Notably recognized within the Q2 category for Obstetrics and Gynecology, it ranks #91 out of 209 in Scopus, placing it in the 56th percentile among its peers. The journal serves as a platform for disseminating innovative research and clinical practices related to assisted reproduction, fostering collaboration and knowledge sharing among professionals in Brazil and beyond. Although currently not an open-access journal, it remains committed to enhancing the scientific discourse in reproductive health, reflecting its vision of supporting advances in healthcare through rigorous peer-reviewed studies. Explore the pivotal contributions made in this field from 2000 to the present, and stay abreast of transformative developments that are shaping reproductive science.

Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.